Intergroup Trial of Adjuvant Chemotherapy in Adenocarcinoma of the Stomach (ITACA-S)
Open Label, Randomised, Multicenter Phase III Study of Adjuvant Chemotherapy in Radically Resected Adenocarcinoma of the Stomach or Gastroesophageal Junction: Comparison of a Sequential Treatment (CPT-11+5-FU/LV --> TXT+CDDP) Versus a 5-FU/LV Regimen
Sponsor: Aventis Pharmaceuticals
A PHASE3 clinical study on Adenocarcinoma of the Gastroesophageal Junction and Adenocarcinoma of the Stomach, this trial is completed. The trial is conducted by Aventis Pharmaceuticals and has accumulated 7 data snapshots since 2005. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.
Status Flow
Change History
7 versions recorded-
Sep 2025 — Present [monthly]
Completed PHASE3
-
Apr 2025 — Sep 2025 [monthly]
Completed PHASE3
-
Sep 2024 — Apr 2025 [monthly]
Completed PHASE3
-
Jul 2024 — Sep 2024 [monthly]
Completed PHASE3
-
Jan 2021 — Jul 2024 [monthly]
Completed PHASE3
▶ Show 2 earlier versions
-
Jun 2018 — Jan 2021 [monthly]
Completed PHASE3
-
Jan 2017 — Jun 2018 [monthly]
Completed PHASE3
First recorded
Feb 2005
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Aventis Pharmaceuticals
- Gruppo Italiano per lo studio dei Carcinomi dell'Apparato Digerente
- Gruppo Oncologico Italiano di Ricerca Clinica
- Gruppo Oncologico del Nord-Ovest
- Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS
- Italian Trial in Medical Oncology
- Mario Negri Institute for Pharmacological Research
- Oncotech
- Southern Italy Cooperative Oncology Group
For direct contact, visit the study record on ClinicalTrials.gov .
Study Locations
Alba, Italy , Antella, Italy , Arezzo, Italy , Ariano Irpino, Italy , Aviano, Italy , Benevento, Italy , Bergamo, Italy , Biella, Italy , Bologna, Italy , Brescia, Italy and 70 more locations